Clinical Variables and Genetic Risk Factors Associated with the Acute Outcome of Ischemic Stroke: A Systematic Review

키워드

참고문헌 (90)

1. Saposnik G, "IScore: a risk score to predict death early after hospitalization for an acute ischemic stroke", Circulation, 123, pp.739~749 (2011)
2. Ibrahim-Verbaas CA, "Predicting stroke through genetic risk functions: the CHARGE Risk Score Project", Stroke, 45, pp.403~412 (2014)
3. Bevan S, "Genetic heritability of ischemic stroke and the contribution of previously reported candidate gene and genomewide associations", Stroke, 43, pp.3161~3167 (2012)
4. Traylor M, "Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies", Lancet Neurol, 11, pp.951~962 (2012)
5. NINDS Stroke Genetics Network, "Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study", Lancet Neurol, 15, pp.174~184 (2016)
6. Malik R, "Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes", Nat Genet, 50, pp.524~537 (2018)
7. Mola-Caminal M, "PATJ low frequency variants are associated with worse ischemic stroke functional outcome", Circ Res, 124, pp.114~120 (2019)
8. Söderholm M, "Genome-wide association meta-analysis of functional outcome after ischemic stroke", Neurology, 92, pp.e1271~e1283 (2019)
9. Lindgren A, "Stroke recovery genetics", Stroke, 47, pp.2427~2434 (2016)
10. Qureshi AI, "Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke", Neurology, 64, pp.2115~2120 (2005)
11. Matsuo R, "Association between onset-to-door time and clinical outcomes after ischemic stroke", Stroke, 48, pp.3049~3056 (2017)
12. Adams HP Jr, "Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST)", Neurology, 53, pp.126~131 (1999)
13. Takagi T, "Early neurologic improvement based on the National Institutes of Health Stroke Scale score predicts favorable outcome within 30 minutes after undergoing intravenous recombinant tissue plasminogen activator therapy", J Stroke Cerebrovasc Dis, 23, pp.69~74 (2014)
14. Liberati A, "The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration", PLoS Med, 6, pp.e1000100~ (2009)
15. Jongbloed L, "Prediction of function after stroke: a critical review", Stroke, 17, pp.765~776 (1986)
16. Kugler C, "Does age influence early recovery from ischemic stroke? A study from the Hessian Stroke Data Bank", J Neurol, 250, pp.676~681 (2003)
17. Boddu DB, "Predictors of major neurological improvement after intravenous thrombolysis in acute ischemic stroke: a hospital-based study from south India", Neurol India, 58, pp.403~406 (2010)
18. Siegler JE, "Identification of modifiable and nonmodifiable risk factors for neurologic deterioration after acute ischemic stroke", J Stroke Cerebrovasc Dis, 22, pp.e207~e213 (2013)
19. Yeo LL, "Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke", J Stroke Cere brovasc Dis, 22, pp.e590~e596 (2013)
20. Naess H, "Ischemic stroke in patients older and younger than 80 years", Acta Neurol Scand, 129, pp.399~404 (2014)
21. Boehme AK, "Racial and gender differences in stroke severity, outcomes, and treatment in patients with acute ischemic stroke", J Stroke Cerebrovasc Dis, 23, pp.e255~e261 (2014)
22. Geng HH, "Early neurological deterioration during the acute phase as a predictor of long-term outcome after first-ever ischemic stroke", Medicine, 96, pp.e9068~ (2017)
23. Roth DL, "Race and gender differences in 1-year outcomes for community-dwelling stroke survivors with family caregivers", Stroke, 42, pp.626~631 (2011)
24. Giralt D, "The gender gap in stroke: a meta-analysis", Acta Neurol Scand, 125, pp.83~90 (2012)
25. Hassaballa H, "Ischemic stroke outcome: racial differences in the trial of danaparoid in acute stroke (TOAST)", Neurology, 57, pp.691~697 (2001)
26. Machumpurath B, "Rapid neurological recoveryafter intravenous tissue plasminogen activator in stroke: prognostic factors and outcome", Cerebrovasc Dis, 31, pp.278~283 (2011)
27. Roquer J, "Ischemic stroke in prediabetic patients", J Neurol, 261, pp.1866~1870 (2014)
28. Tang H, "Unfavorable neurological outcome in diabetic patients with acute ischemic stroke is associated with incomplete recanalization after intravenous thrombolysis", J Neurointerv Surg, 8, pp.342~346 (2016)
29. Yi X, "Antiplatelet drug resistance is associated with early neurological deterioration in acute minor ischemic stroke in the Chinese population", J Neurol, 263, pp.1612~1629 (2016)
30. Hui J, "The initial glycemic variability is associated with early neurological deterioration in diabetic patients with acute ischemic stroke", Neurol Sci, 39, pp.1571~1577 (2018)
31. Forlivesi S, "Association of hyperglycemia, systolic and diastolic hypertension, and hyperthermia relative to baseline in the acute phase of stroke with poor outcome after intravenous thrombolysis", Blood Coagul Fibrinolysis, 29, pp.167~171 (2018)
32. Vlcek M, "Association between course of blood pressure within the first 24 hours and functional recovery after acute ischemic stroke", Ann Emerg Med, 42, pp.619~626 (2003)
33. Castillo J, "Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome", Stroke, 35, pp.520~526 (2004)
34. Pezzini A, "Influence of acute blood pressure on short- and midterm outcome of ischemic and hemorrhagic stroke", J Neurol, 258, pp.634~640 (2011)
35. Geeganage C, "Relationship between baseline blood pressure parameters (including mean pressure, pulse pressure, and variability) and early outcome after stroke: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST)", Stroke, 42, pp.491~493 (2011)
36. Kvistad CE, "Elevated admission blood pressure and stroke severity in acute ischemic stroke: the Bergen NORSTROKE Study", Cerebrovasc Dis, 36, pp.351~354 (2013)
37. Chung JW, "Blood pressure variability and the development of early neurological deterioration following acute ischemic stroke", J Hypertens, 33, pp.2099~2106 (2015)
38. Gill D, "A fall in systolic blood pressure 24 hours after thrombolysis for acute ischemic stroke is associated with early neurological recovery", J Stroke Cerebrovasc Dis, 25, pp.1539~1543 (2016)
39. Kellert L, "Reciprocal interaction of 24-hour blood pressure variability and systolic blood pressure on outcome in stroke thrombolysis", Stroke, 48, pp.1827~1834 (2017)
40. Kang J, "Change in blood pressure variability in patients with acute ischemic stroke and its effect on early neurologic outcome", PLoS One, 12, pp.e0189216~ (2017)
41. Keezer MR, "Blood pressure and antihypertensive therapy as predictors of early outcome in acute ischemic stroke", Cerebrovasc Dis, 25, pp.202~208 (2008)
42. Sare GM, "Relationship between hyperacute blood pressure and outcome after ischemic stroke: data from the VISTA collaboration", Stroke, 40, pp.2098~2103 (2009)
43. Zhang YB, "Early neurological deterioration after recanalization treatment in patients with acute ischemic stroke: a retrospective study", Chin Med J, 131, pp.137~143 (2018)
44. Wolf PA, "Atrial fibrillation as an independent risk factor for stroke: the Framingham Study", Stroke, 22, pp.983~988 (1991)
45. Sanák D, "Is atrial fibrillation associated with poor outcome after thrombolysis?", J Neurol, 257, pp.999~1003 (2010)
46. Yaghi S, "Predictors of major improvement after intravenous thrombolysis in acute ischemic stroke", Int J Neurosci, 126, pp.67~69 (2016)
47. Restrepo L, "Impact of hyperlipidemia and statins on ischemic stroke outcomes after intra-arterial fibrinolysis and percutaneous mechanical embolectomy", Cerebrovasc Dis, 28, pp.384~390 (2009)
48. Choi KH, "Serum triglyceride level is an important predictor of early prognosis in patients with acute ischemic stroke", J Neurol Sci, 319, pp.111~116 (2012)
49. Strazzullo P, "Excess body weight and incidence of stroke: metaanalysis of prospective studies with 2 million participants", Stroke, 41, pp.e418~e426 (2010)
50. Andersen KK, "The obesity paradox in stroke: lower mortality and lower risk of readmission for recurrent stroke in obese stroke patients", Int J Stroke, 10, pp.99~104 (2015)
51. Branscheidt M, "No impact of body mass index on outcome in stroke patients treated with IV thrombolysis BMI and IV thrombolysis outcome", PLoS One, 11, pp.e0164413~ (2016)
52. Hojs Fabjan T, "Stroke and renal dysfunction", Eur J Intern Med, 25, pp.18~24 (2014)
53. Power A, "Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke", Cerebrovasc Dis, 35, pp.45~52 (2013)
54. Lo WT, "Thrombolysis in Chinese ischemic stroke patients with renal dysfunction", Interv Neurol, 3, pp.101~106 (2015)
55. Gao CY, "Association of dementia with death after ischemic stroke: a twoyear prospective study", Exp Ther Med, 12, pp.1765~1769 (2016)
56. Yu AY, "Pre-stroke use of antihypertensives, antiplatelets, or statins and early ischemic stroke outcomes", Cerebrovasc Dis, 27, pp.398~402 (2009)
57. Tsai NW, "Statin pre-treatment is associated with lower platelet activity and favorable outcome in patients with acute noncardio-embolic ischemic stroke", Crit Care, 15, pp.R163~ (2011)
58. Ní Chróinín D, "Association between acute statin therapy, survival, and improved functional outcome after ischemic stroke: the North Dublin Population Stroke Study", Stroke, 42, pp.1021~1029 (2011)
59. Tsivgoulis G, "Safety of statin pretreatment in intravenous thrombolysis for acute ischemic stroke", Stroke, 46, pp.2681~2684 (2015)
60. Yi X, "Statin and aspirin pretreatment are associated with lower neurological deterioration and platelet activity in patients with acute ischemic stroke", J Stroke Cerebrovasc Dis, 26, pp.352~359 (2017)
61. Cappellari M, "Does statin in the acute phase of ischemic stroke improve outcome after intravenous thrombolysis? A retrospective study", J Neurol Sci, 308, pp.128~134 (2011)
62. Smith EE, "Leukoaraiosis and stroke", Stroke, 41(10 Suppl), pp.S139~S143 (2010)
63. McAlpine H, "Leukoaraiosis and early neurological recovery after intravenous thrombolysis", J Stroke Cerebrovasc Dis, 23, pp.2431~2436 (2014)
64. Saposnik G, "Variables associated with 7-day, 30-day, and 1-year fatality after ischemic stroke", Stroke, 39, pp.2318~2324 (2008)
65. Kim DH, "Factors associated with early dramatic recovery following successful recanalization of occluded artery by endovascular treatment in anterior circulation stroke", J Clin Neurosci, 46, pp.171~175 (2017)
66. Schmitz ML, "Ischemic stroke subtype is associated with outcome in thrombolyzed patients", Acta Neurol Scand, 135, pp.176~182 (2017)
67. Forlivesi S, "Stroke etiologic subtype may influence the rate of hyperdense middle cerebral artery sign disappearance after intravenous thrombolysis", J Thromb Thrombolysis, 43, pp.86~90 (2017)
68. Ciccone A, "Endovascular treatment for acute ischemic stroke", N Engl J Med, 368, pp.904~913 (2013)
69. Saver JL, "Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke", N Engl J Med, 372, pp.2285~2295 (2015)
70. Jovin TG, "Thrombectomy within 8 hours after symptom onset in ischemic stroke", N Engl J Med, 372, pp.2296~2306 (2015)
71. Fiorelli M, "Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort", Stroke, 30, pp.2280~2284 (1999)
72. Kablau M, "Predictors and early outcome of hemorrhagic transformation after acute ischemic stroke", Cerebrovasc Dis, 32, pp.334~341 (2011)
73. Dharmasaroja PA, "Early outcome after intravenous thrombolysis in patients with acute ischemic stroke", Neurol India, 59, pp.351~354 (2011)
74. Gill D, "Severe hemorrhagic transformation after thrombolysis for acute ischemic stroke prevents early neurological improvement", J Stroke Cerebrovasc Dis, 25, pp.2232~2236 (2016)
75. Clausen BH, "Fumarate decreases edema volume and improves functional outcome after experimental stroke", Exp Neurol, 295, pp.144~154 (2017)
76. Kumar S, "Medical complications after stroke", Lancet Neurol, 9, pp.105~118 (2010)
77. Boehme AK, "Infections present on admission compared with hospital-acquired infections in acute ischemic stroke patients", J Stroke Cerebrovasc Dis, 22, pp.e582~e589 (2013)
78. Strecker JK, "Neutrophil granulocytes in cerebral ischemia: evolution from killers to key players", Neurochem Int, 107, pp.117~126 (2017)
79. Maestrini I, "Higher neutrophil counts before thrombolysis for cerebral ischemia predict worse outcomes", Neurology, 85, pp.1408~1416 (2015)
80. Nardi K, "Admission leukocytosis in acute cerebral ischemia: influence on early outcome", J Stroke Cerebrovasc Dis, 21, pp.819~824 (2012)
81. Kumar AD, "Leukocytosis in patients with neurologic deterioration after acute ischemic stroke is associated with poor outcomes", J Stroke Cerebrovasc Dis, 22, pp.e111~e117 (2013)
82. Tian C, "Association of lower leukocyte count before thrombolysis with early neurological improvement in acute ischemic stroke patients", J Clin Neurosci, 56, pp.44~49 (2018)
83. Pósfai É, "Stroke in essential thrombocythemia", J Neurol Sci, 336, pp.260~262 (2014)
84. Furlan JC, "Outcomes after acute ischemic stroke in patients with thrombocytopenia or thrombocytosis", J Neurol Sci, 362, pp.198~203 (2016)
85. Turcato G, "Red blood cell distribution width is an independent predictor of outcome in patients undergoing thrombolysis for ischemic stroke", Semin Thromb Hemost, 43, pp.30~35 (2017)
86. Pinho J, "Red cell distribution width as a predictor of 1-year survival in ischemic stroke patients treated with intravenous thrombolysis", Thromb Res, 164, pp.4~8 (2018)
87. Furlan JC, "Acute ischemic stroke and abnormal blood hemoglobin concentration", Acta Neurol Scand, 134, pp.123~130 (2016)
88. Yi X, "CYP genetic variants, CYP metabolite levels, and neurologic deterioration in acute ischemic stroke in Chinese population", J Stroke Cerebrovasc Dis, 26, pp.969~978 (2017)
89. Yi X, "Variants in COX-2, PTGIS, and TBXAS1 are associated with carotid artery or intracranial arterial stenosis and neurologic deterioration in ischemic stroke patients", J Stroke Cerebrovasc Dis, 26, pp.1128~1135 (2017)
90. Yi X, "Interaction among COX-2, P2Y1 and GPIIIa gene variants is associated with aspirin resistance and early neurological deterioration in Chinese stroke patients", BMC Neurol, 17, pp.4~ (2017)

관련 논문AI추천